Bronchioloalveolar carcinoma is not associated with younger age at diagnosis: An analysis of the SEER database

Journal of Thoracic Oncology

Volumn 1, Issue 4, 2006, Pages 339-343

  Raz, Dan J ^a,b   Jablons, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age; Bronchioloalveolar carcinoma; Epidemiology; Lung cancer

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; FEMALE; HISTOLOGY; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; WORLD HEALTH ORGANIZATION; AGE; CANCER REGISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MIDDLE AGED;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; DATABASES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SEER PROGRAM;

EID: 34247224361     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01243894-200605000-00013     Document Type: Article

References (18)

1. Auerbach O, Garfinkel L. The changing pattern of lung carcinoma. Cancer 1991;68:1973-1977.
2. Barsky SH, Cameron R, Osann KE, Tomita D, Holmes EC. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer 1994;73:1163-1170.
3. Gandara DR, West H, Chansky K, et al. Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition. Clin Cancer Res 2004;10:4205s-4209s.
4. Hsieh RK, Lim KH, Kuo HT, Tzen CY, Huang MJ. Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer. Chest 2006;128:317-321.
5. Miller VA, Kris MG, Shah N, et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol 2004;22:1103-1109.
6. Barkley JE, Green MR. Bronchioloalveolar carcinoma. J Clin Oncol 1996;14:2377-2386.
7. Furak J, Trojan I, Szoke T, et al. Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival. Eur J Cardiothorac Surg 2003;23:818-823.
8. Okubo K, Mark EJ, Flieder D, et al. Bronchoalveolar carcinoma: clinical, radiologic, and pathologic factors and survival. J Thorac Cardiovasc Surg 1999;118:702-709.
9. Liu YY, Chen YM, Huang MH, Perng RP. Prognosis and recurrent patterns in bronchioloalveolar carcinoma. Chest 2000;118:940-947.
10. Sasatomi E, Johnson LR, Aldeeb DN, et al. Genetic profile of cumulative mutational damage associated with early pulmonary adenocarcinoma: bronchioloalveolar carcinoma vs. stage I invasive adenocarcinoma. Am J Surg Pathol 2004;28:1280-1288.
11. Aida S, Shimazaki H, Sato K, et al. Prognostic analysis of pulmonary adenocarcinoma subclassification with special consideration of papillary and bronchioloalveolar types. Histopathology 2004;45:468-476.
12. Rena O, Papalia E, Ruffini E, et al. Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung. Eur J Cardiothorac Surg 2003;23:409-414.
13. Read WL, Page NC, Tierney RM, Piccirillo JF, Govindan R. The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database. Lung Cancer 2004;45:137-142.
14. Zell JA, Ou SH, Ziogas A, Anton-Culver H. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol 2006;23:8396-8405.
15. Travis WD, Colby TV, Corrin B, et al. Histological typing of lung and pleural tumours, 3rd Ed. Berlin: Springer, 1998.
16. Ebright MI, Zakowski MF, Martin J, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg 2002;74:1640-1646.
17. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer 1995;75:2844-2852.
18. Terasaki H, Niki T, Matsuno Y, et al. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol 2003;27:937-951.